Clinical Trials List
2024-09-01 - 2028-12-31
Phase III
Recruiting14
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃偉銘 無
- Kang-Ling Wang Division of Cardiovascular Diseases
- Chern-En Chiang 臨床試驗科
- 李慶威 無
- Tze-Fan Chao 無
- 蔡泉財 Division of Cardiovascular Diseases
- 吳承學 無
- 郭泠 無
- Tse-Min Lu 無
- Wen-Chung Yu 無
- 張俊欽 無
- 蔡依霖 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 江君揚 無
- 林柏志 無
- 洪啟盛 無
- 蔡承烜 無
- CHO-KAI WU 無
- MAO-HSIN LIN 無
- 陳盈憲 無
- 鄭人方 無
- Yi-Chih Wang 無
- YEN-HUNG LIN 無
- 柯宗佑 無
- Chih-Fan Yeh 無
- 孟士瑋 Division of Cardiovascular Diseases
- Tzung-Dau Wang 無
- HUNG-JU LIN 無
- 黃慶昌 無
- 張皓雲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳韋璁 無
- 黃天祈 無
- Chun-Yuan Chu 無
- Po-Chao Hsu 無
- Cheng-An Chiu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張惟智 Division of Cardiovascular Diseases
- 楊秉忠 Division of Cardiovascular Diseases
- 李政良 Division of Cardiovascular Diseases
- 黃宏凱 Division of Cardiovascular Diseases
- 簡思齊 Division of Cardiovascular Diseases
- 王聖云 Division of Cardiovascular Diseases
- 廖英傑 Division of Cardiovascular Diseases
- 陳美綾 Division of Cardiovascular Diseases
- 楊淵博 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
189 participants
-
Global
14000 participants